Abstract
Contouring organs-at-risk (OARs) is a critical yet time-consuming step in head and neck (HaN) radiotherapy planning. Auto-segmentation methods have been widely studied, and commercial solutions are increasingly entering clinical use. However, their adoption warrants a comprehensive, multi-perspective evaluation. The purpose of this study is to compare three commercial artificial intelligence (AI) software solutions (Limbus, MIM and MVision) for HaN OAR auto-segmentation on a cohort of 10 computed tomography images with reference contours obtained from the public HaN-Seg dataset, from both observational (descriptive and empirical) and analytical (geometric, dosimetric and psychometric) perspectives. The observational evaluation included vendor questionnaires on technical specifications and radiographer feedback on usability. The analytical evaluation covered geometric (Dice similarity coefficient, DSC, and 95th percentile Hausdorff distance, HD95), dosimetric (dose constraint compliance, OAR priority-based analysis), and psychometric (5-point Likert scale) assessments. All software solutions covered a broad range of OARs. Overall geometric performance differences were relatively small (Limbus: 69.7% DSC, 5.0 mm HD95; MIM: 69.2% DSC, 5.6 mm HD95; MVision: 66.7% DSC, 5.3 mm HD95), however, statistically significant differences were observed for smaller structures such as the cochleae, optic chiasm, and pituitary and thyroid glands. Differences in dosimetric compliance were overall minor, with the lowest compliance observed for the oral cavity and submandibular glands. In terms of qualitative assessment, radiographers gave the highest average Likert rating to Limbus (3.9), followed by MVision (3.7) and MIM (3.5). With few exceptions, most software solutions produced good-quality AI-generated contours (Likert ratings ≥ 3), yet some editing should still be performed to reach clinical acceptability. Notable discrepancies were seen for the optic chiasm and in cases affected by mouth bites or dental artifacts. Importantly, no clear relationship emerged between geometric, dosimetric, and psychometric metrics, underscoring the need for a multi-perspective evaluation without shortcuts.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-025-18598-3.
Keywords: Head and neck radiotherapy; Organ-at-risk auto-segmentation; Computed tomography; Artificial intelligence; Commercial software; Observational (descriptive and empirical) evaluation; Analytical (geometric, dosimetric and psychometric) evaluation
Subject terms: Cancer imaging, Head and neck cancer, Software, Computational science, Image processing, Software, Machine learning
Introduction
Radiotherapy (RT) requires precise planning to deliver therapeutic doses of ionizing radiation to the tumor while protecting the surrounding healthy tissues, known as organs-at-risk (OARs). Accurate delineation of the tumor and OARs from the acquired planning images is critical to ensure local tumor control and prevent damage to normal tissue. The delineation process is typically done manually and relies heavily on the expertise of radiation oncologists, radiographers, and dosimetrists. However, numerous studies have shown that manual delineations are subjective, prone to errors, and very time-consuming1. The automation of the contouring process has been long a major research and application focus in RT, which has, in the past decade, witnessed the transition from atlas-based to artificial intelligence (AI) methods that attempt to provide accurate auto-segmentations of tumors and OARs2,3. Moreover, with the introduction of adaptive RT, auto-segmentation is becoming paramount as it facilitates rapid adjustments to treatment plans in response to daily anatomical changes4–6.
To address these challenges, several AI algorithms have been developed that make use of deep learning models, which are trained on annotated datasets to learn the patterns and features associated with different anatomical tissues and organs, and then applied to analyze medical images and perform auto-segmentation of the same structures on new images7. These algorithms typically employ convolutional neural network (CNN) architectures, such as U-Net8 and its variants, with nnU-Net9 standing out as an open-source framework that provides a fully automated pipeline as well as self-configuration to the characteristics of the provided dataset. Recently, novel frameworks such as TotalSegmentator10 or Segment-Anything-Model11,12 have started to gain acceptance, especially because they are pre-trained on large standardized datasets. As a result, several commercial AI solutions have emerged to facilitate the contouring process13, which vary considerably in terms of the number of structures and types of images that can be contoured, the methods used to seamlessly integrate the software within the RT workflow, and overall software usability. With the availability of commercial solutions, studies focusing on their comparison and clinical acceptability have emerged14, reporting that the performance of these software solutions can differ in accuracy and consistency across diverse patient populations.
From this perspective, the head and neck (HaN) cancer is particularly challenging to treat with RT since this region is surrounded by a large number of lymph nodes and OARs15–18, which is also reflected in the number of studies comparing the commercial software solutions for HaN cancer site19–40 (Table 1). While these comparison studies focus on multiple software solutions, few of them perform their complete assessment (Fig. 1) from an observational and analytical perspective. While observational evaluation can be divided into descriptive evaluation, which encompasses various surveys and questionnaires, and empirical evaluation, which is more useful as it may consist of user-feedback on the AI-generated contours or even their manual corrections, analytical evaluation is the primary focus of such studies because it results in measurable properties. In fact, all existing studies (Table 1) performed geometric evaluation, which refers to the quantitative assessment of the spatial agreement between the AI-generated and reference contours using the geometric metrics, such as the Dice similarity coefficient (DSC) or Hausdorff distance (HD) with its 95th percentile (HD95). On the other hand, relatively few of them complement the geometric evaluation with dosimetric evaluation, which assesses how quantitative differences in contouring affect the radiation dose distribution received by OARs or target volumes using the dosimetric metrics, such as the average dose (Dmean), maximal dose (Dmax) or dose-volume histogram (DVH), or with psychometric evaluation, which encompasses standardized techniques involving human judgment of contour quality, such as Likert ratings or Turing tests. All three evaluations were performed only in the studies of Heilemann et al.24 and Chen et al.27, but their dosimetric analysis is limited to reporting deviations in only in terms of Dmean, Dmax and/or DVH, which is an overly generalized approach that does not adequately reflect clinical decision-making, which commonly relies on specific dosimetric constraints and OAR prioritization41,42. Another relevant aspect is the time-based evaluation that measures the time differences between manual contouring and AI auto-segmentations or even manual corrections of AI-generated contours, however, a substantial body of evidence already demonstrates that AI auto-segmentation algorithms can considerably accelerate the auto-segmentation process1. Last but not least, it is important to note that the large amount of data required to train these algorithms raises ethical concerns regarding data privacy, patient consent and dataset representativeness39.
Table 1.
An overview of the studies comparing commercial software that perform auto-segmentation of organs-at-risk (OARs) for head and neck radiotherapy planning using artificial intelligence.
| Study | Software solutions | Data | Observational evaluation | Analytical evaluation | |||||
|---|---|---|---|---|---|---|---|---|---|
| # Cases | # OARs | Descriptive | Empirical | Geometric | Dosimetric | Psychometric | |||
| D’Aviero et al.19 (2022) | Limbus Contour | 12 | 16 | × | × | DSC | HD95 | × | × | |
| Hobbis et al.20 (2022) | 5 anonymized | 35 | 42 | × | × | DSC | × | × | |
| Radici et al.21 (2022) | Limbus Contour | – | 15 | × | × | DSC | VOLv | DVH | Dmean | Dmax | × | |
| Anaya22 (2023) | Limbus Contour | AI-Rad Companion | 10 | 4 | × | × | DSC | MDC | DVH | × | |
| Doolan et al.23 (2023) |
Mirada Contouring | MVision Contour | AutoContour | RayStation | Annotate |
20 | 17 | × | × |
DSC | sDSC | HD | APL |
× | × | |
| Heilemann et al.24 (2023) | Annotate | Limbus Contour | RayStation | 15 | 13 | × | × | DSC | HD | Dmean | Dmax | 4-Likert | |
| Hoque et al.25 (2023) | Limbus Contour | 40 | 19 | × | Plan quality metric | DSC | rVOLd | Dmean | Dmax | 4-Likert | |
| Hu et al.26 (2023) | AI-Rad Companion | Smart Segmentation | 8 | 11 | × | × | DSC | HD | × | 4-Likert | |
| Chen et al.27 (2024) | RayStation | 98 | 11 | × | Failure modes | DSC | sDSC | HD95 | DVH | 4-Likert | |
| Johnson et al.28 (2024) | AccuContour | Contour ProtegeAI | 40 | 22 | × | × | DSC | MD | × | × | |
| Kim et al.29 (2024) |
Limbus Contour | Contour ProtegeAI | AutoContour | Radiotherapy AI | AI-Rad Companion | ART-Plan |
10 | 8 | × | × | DSC | sDSC | HD | × | × | |
| Lê et al.30 (2024) | ART-Plan | 74 | 2 | Questionnaire | Manual corrections | DSC | HD95 | MSD | × | 3-Likert | |
| Luan et al.31 (2024) |
AutoContour | PV-iRT | Haichuang | RT-Viewer-contour |
68 | 7 | × | × | DSC | HD | × | × | |
| Maes et al.32 (2024) |
Contour ProtegeAI | RayStation | Limbus Contour |
20 | 9 | Questionnaire | × | DSC | HD | × | 4-Likert | |
| Mody et al.33 (2024) | RayStation | 100 | 8 | × | × | DSC | sDSC | HD95 | MSD | Dmean | NTCP | × | |
| Moktan et al.34 (2024) | AutoContour | Limbus Contour | Elements | 15 | 4 | × | × | DSC | aVOL | COM | × | 3-Likert | |
| Sarria et al.35 (2024) | Limbus Contour | 25 | 11 | × | Manual corrections | DSC | Dmean | Dmax | × | |
|
Temple and Rowbottom 36 (2024) |
Mirada DLCExpert |
50 500 |
3 | × | × | DSC | × | × | |
| Way et al.37 (2024) | Contour ProtegeAI | AutoContour | – | – | × | User-feedback | DSC | HD | × | × | |
| Finnegan et al.38 (2025) | Ethos AI | 28 | 16 | × | × | DSC | sDSC | HD | MDA | Dmean | Dmax | × | |
| Rusanov et al.39 (2025) |
Limbus Contour | AutoContour | Contour ProtegeAI | MVision Contour | ART-Plan | 1 anonymized |
20 | 14 | × | × | DSC | sDSC | HD95 | ASD | APL | × | 5-Likert | |
| Sharma et al.40 (2025) | RayStation | 124 | 21 | × | Manual corrections | DSC | HD | aVOL | Dmean | Dmax | × | |
| Our study (2025) |
Limbus Contour | Contour ProtegeAI | MVision Contour |
10 | 13 | Questionnaire | User-feedback | DSC | HD95 |
Dmean | Dmax | VX | PL |
5-Likert | |
Abbreviations – DSC: Dice similarity coefficient; sDSC: Surface Dice; HD: Hausdorff distance; HD95: 95th percentile HD; APL: Added path length; MDC: Mean distance to conformity; MDA: Mean distance to agreement; ASD: Average surface distance; VOLv: Volume variation; aVOL: Absolute volume; rVOLd: Relative volume difference; DVH: Dose-volume histogram; Dmean: Average dose; Dmax: Maximal dose; NTCP: Normal tissue complication probability; VX: Amount of volume receiving more than X Gy of dose; PL: Dosimetric priority level L; N-Likert: N-point Likert scale.
Notes – Radici et al.21, Doolan et al.23, Hoque et al.25, Hu et al.26, Sarria et al.35 and Sharma et al.40 performed also time-based evaluation.
Vendors – Limbus Contour: Limbus AI (part of Radformation); AI-Rad Companion: Siemens Healthineers; Mirada Contouring & Mirada DLCExpert: Mirada Medical; MVision Contour: MVision AI; AutoContour: Radformation; RayStation: RaySearch; Annotate: TheraPanacea; Smart Segmentation: Varian (part of Siemens Healthineers); AccuContour: Manteia Medical; Contour ProtegeAI: MIM Software (part of GE HealthCare); ART-Plan: TheraPanacea; PV-iRT: PVmed; Haichuang: Haichuang Medical Company; RT-Viewer-contour: Linking Med; Elements: Brainlab; Ethos AI: Varian (part of Siemens Healthineers).
Fig. 1.

A diagram showing the conceptual design of this study: observational (left) and analytical (right) evaluation.
The rapid evolution of AI auto-segmentation algorithms therefore necessitates a thorough evaluation to ensure that these solutions can meet the legal and ethical requirements as well as the demands of clinical practice. As none of the existing studies (Table 1 encompasses the whole spectrum of observational and analytical evaluations in Fig. 1), this study therefore aims to fill this gap by systematically performing a multi-perspective evaluation of three commercial solutions for auto-segmentation of OARs from a publicly available dataset of HaN images to provide clinicians, researchers, hospital administrators and policymakers with evidence-based insights into their strengths and limitations, and hence facilitate the safe integration of these technologies into clinical practice.
Methods
Experimental setup
Data The recently published publicly available HaN-Seg dataset43, which consists of paired computed tomography (CT) and magnetic resonance (MR) images of the same patients with corresponding manually obtained three-dimensional contours for up to 30 OARs in the HaN region, was used in this study. Manual delineations were performed by an RT technologist or radiation oncologist, and then curated by a medical imaging researcher following established delineation guidelines44, aided by co-registered MR images to improve the delineation of soft tissues16, with the overall inter-observer variability in contouring OARs from CT images estimated to 71.2 ± 18.2% and 4.9 ± 4.1 mm in terms of DSC and HD95, respectively16. From the HaN-Seg dataset, which was also used for the recently organized HaN-Seg segmentation challenge45, 10 representative cases were selected to include both straightforward cases – hereinafter referred to as normal cases (n = 3: case_02, case_08, case_12), and common clinical challenges such as mouth bites (n = 3: case_15, case_23, case_34) and artifacts (n = 4: case_05, case_22, case_26, case_27). The extracted CT images, acquired using either the Philips Brilliance Big Bore (Philips Healthcare, Best, the Netherlands) or Siemens Somatom Definition AS (Siemens Healthineers, Erlangen, Germany) scanner, were retained at their original resolution (in-plane resolution: 0.56–0.98 mm; slice thickness: 2.0–3.0 mm) and converted from the originally released NIfTI to DICOM format before being uploaded to the AI software, with no dedicated metal artifact reduction techniques46 applied before further processing. For the purpose of this study, the dataset was complemented with corresponding clinical RT dose distributions maps in the DICOM RTDOSE format, generated using the Varian Eclipse treatment planning system (Varian, Palo Alto, CA, USA). Out of 10 cases, one was treated with intensity modulated RT (IMRT; Monte Carlo algorithm, 7 fields and 35 × 2.0/1.6 fractionation), while the remaining nine received volumetric modulated arc therapy (VMAT; analytical anisotropic algorithm, six with 2 × 360° arcs and 35 × 2.0/1.6 fractionation, one with 2 × 210° arcs and 35 × 2.0/1.6 fractionation, one with 220° + 80° arcs and 30 × 2.0 fractionation, one with 2 × 220° arcs and 33 × 2.0/1.7 fractionation).
Software Six commercial software companies that include AI auto-segmentation of OARs for the HaN region in their portfolio were invited, and three accepted to participate in this study: (i) Limbus AI (Regina, SK, Canada) – part of Radformation Inc. (New York, NY, USA) – with software Limbus Contour v1.7.0, (ii) MIM Software Inc. (Cleveland, OH, USA) – part of GE HealthCare Inc. (Chicago, IL, USA) – with software Contour ProtegeAI v7.3.5 and (iii) MVision AI (Helsinki, Finland) with software MVision Contour v1.2. The corresponding software are hereinafter referred to as Limbus, MIM and MVision, respectively, and were used to segment 13 OARs in the devised dataset: brainstem, cochleae (left, L/right, R), lacrimal glands (L/R), lips, mandible, optic chiasm, optic nerves (L/R), oral cavity, parotid glands (L/R), pituitary gland, spinal cord, submandibular glands (L/R) and thyroid. All AI-generated contours were produced using the cloud-based software and exported locally as DICOM RTSTRUCT files, which were then converted back to NIfTI format for further evaluation.
Compliance with ethical standards All procedures in this study were performed in accordance with the institutional guidelines and ethical standards of the Declaration of Helsinki. The study was approved by the ethical committee of the Institute of Oncology Ljubljana, Slovenia (approval no. ERID-EK/139), which also waived the requirement for informed consent from the study subjects due to the retrospective study design.
Code availability The code for performing numerical evaluations and statistical analyses was developed in SciPy, an open-source Python library for scientific and technical computing (https://scipy.org/), and is available from the corresponding author upon reasonable request. The geometric performance metrics were computed using the recently released open-source software MeshMetrics, version v0.1.047,48 (10.5281/zenodo.16896595).
Observational evaluation
Descriptive evaluation The participating companies were asked to complete a technical specification questionnaire about their software, consisting of six sections with a total of 28 questions (Q) that were based on literature findings49 and consultations with radiographers: (1) general information about the company (2Q), (2) methodological design and algorithm validation (10Q), (3) compliance of the AI software with legal and hospital standards (5Q), (4) software interoperability and data management (3Q), (5) supported anatomies, OARs, and tumor sites (6Q), and (6) additional features for contouring support (2Q).
Empirical evaluation Two radiographers were invited to provide qualitative comments on the AI-generated contours for each case.
Analytical evaluation
Geometric evaluation The MeshMetrics software47,48 was used to compute the volumetric DSC and HD95 between the AI-generated and curated reference contours, defined as DSC = 2|X∩Y|/(|X|+|Y|) and HD95 = max{dk95%(X,Y), dk95%(Y,X)}, where X and Y are the two volumetric contours being compared, |X|, |Y| and |X∩Y| represent the number of voxels in X, Y, and their volumetric overlap, respectively, while dk95%(X,Y) and dk95%(Y,X) denote the 95th percentile of the Euclidean distances from voxels in X to the surface of Y, and vice versa. Although other metrics for evaluating the segmentation quality exist, such as those derived from radiomic features50, DSC and HD95 remain standard geometric benchmarks in RT workflows. DSC is a relative metric that quantifies volumetric overlap, with 100% indicating perfect and 0% no overlap, which is sensitive to the count of true positive voxels relative to both contours. While it is robust to small contour shifts in large structures, it also heavily penalizes the same absolute error in the case of small structures. On the other hand, HD95 is an absolute metric that is typically expressed in millimeters, and is only lower-bounded, with 0 mm indicating a very close alignment between the two contours. It is less sensitive to extreme outliers than HD, and serves to identify local contour mismatches even when overall volume overlap is high. However, it is still sensitive to small segmentation errors in the case of small, complex or irregular structures.
Dosimetric evaluation A forward dosimetric analysis was performed to evaluate the dosimetric impact of the AI auto-segmentations51,52. A single dose distribution, originally created at the Institute of Oncology Ljubljana, Slovenia, during RT planning based on the selected CT image in the HaN-Seg dataset and corresponding clinical segmentations of OARs, was projected onto both AI-generated and curated reference contours. Although a variety of dosimetric metrics exist, including those based on the recently introduced field of dosiomics53, we computed Dmean, Dmax and the amount of volume receiving more than 54 Gy of dose (V54 Gy) that are among the standard dosimetric benchmarks in RT workflows. Compliance with clinical dose constraints and priority-based analysis was conducted based on OAR-specific international guidelines41,42,54,55 that are routinely applied in clinical practice.
Psychometric evaluation Two radiographers were asked to evaluate the quality of the AI-generated contours using a 5-point Likert scale56: 1 – unusable, 2 – major edits required, 3 – minor edits that are necessary required, 4 – minor edits that are not necessary are required, 5 – clinically acceptable. One case was re-evaluated to assess the intra-rater reliability. For this analysis, only the OARs contoured at our department were considered (i.e. brainstem, cochlea, mandible, optic chiasm, optic nerves, parotid glands, spinal cord). The intra-rater agreement was evaluated by the Kendall rank correlation coefficient (τ)57 that measures the ordinal association between two measured quantities (τ = −1: perfect disagreement, reverse ranking; τ = 0: no correlation, random ranking; τ = +1: perfect agreement, identical ranking).
Relationships between metrics We investigated the relationship between average Likert ratings and two geometric metrics, DSC and HD95, as well as the inter-rater agreement for each OAR. Additionally, leveraging the diverse set of available metrics (Fig. 1), we performed a correlation analysis across all AI software solutions using the Pearson (r) and Spearman (ρ) coefficients57, which measure the linear and monotonic relationships between two variables according to their values and ranks, respectively (r, ρ = −1: perfect negative linear/monotonic decreasing relationship; r, ρ = −0: no linear/monotonic relationship; r, ρ = +1: perfect positive linear/monotonic increasing relationship). This analysis included DSC, HD95, Dmax, Dmean, average Likert ratings, and distance to target, aiming to visualize and explore the potential relationships within the analytical metric triangle: geometric, dosimetric, and psychometric.
Results
Observational evaluation
Descriptive evaluation The findings of the questionnaire are presented in detail in Supplementary Material, Table S1, and can be, at the time of writing, summarized as follows:
Market share The market share of the software companies ranged from 100 to 470 hospitals.
Methods used to develop the algorithm All software solutions made use of a convolutional neural network based on the U-Net architecture45. The data used to develop the algorithms was obtained from clinical hospitals and open-source databases. A large number of images from different scanners encompassing a wide range of clinical cases was used by all software companies to ensure the generalizability of the AI software. In addition, Limbus also included diagnostic CT and MR linac data to further improve the generalizability of the model. All software companies made use of a wide range of clinical guidelines to develop the AI models according to the structure being delineated. MVision offered the option to delineate some OARs according to the preferred guideline, such as those of the Danish Head and Neck Cancer Group (DAHANCA), European Organisation for Research and Treatment of Cancer (EORTC), Groupe d’Oncologie Radiothérapie Tête et Cou (GORTEC), Head and Neck Cancer Program Study Group (HKNPCSG), National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), National Cancer Research Institute (NCRI), NRG Oncology and Trans-Tasman Radiation Oncology Group (TROG), united under the multi-national consensus guidelines of Brouwer et al.44. All software companies asked medical or radiation oncologists working within the company and at various clinical centers to segment the images. However, MVision also involved medical and dental students for the initial segmentations. All software companies made use of multidisciplinary peer review to assess the quality of the segmentations used for both training and validation. The quality of the algorithms was assessed quantitatively by geometric metrics (e.g. DSC and HD95) and qualitatively by experts. All companies collaborated with clinical centers to assess the quality of the algorithms and collected additional data on the impact of introducing AI on the segmentation time, inter-rater agreement, and dosimetry of any deviations in the AI segmentation from the gold standard contours.
Certification and data management All software solutions are marked with European conformity (i.e. CE-marked). MVision and MIM offered a cloud or hospital-based storage system, while Limbus offered only a hospital-based storage system. For the cloud-based solution of both MVision and MIM, the data is pseudonymised before sent to the segmentation software available on the cloud. All solutions offered a user authentication feature. MVision and MIM can audit user trail events, however, Limbus can log events but does not provide a user trail.
Interoperability with RT systems All software solutions offered seamless integration with the main RT equipment vendors. This feature enabled the users to seamlessly import and export data into the RT planning station, thus facilitating the editing of structures without the need to learn new features.
Type of delineation models offered The software solutions varied in the number of OARs offered: MVision offered the highest number of HaN OARs for CT (n = 32), followed by Limbus (n = 22) and MIM (n = 18). Moreover, Limbus and MVision offered the option to assist the hospital with the development of AI models if required.
Additional features All software solutions offered a quality assurance tool to quantitatively assess the quality of the AI auto-segmentation models. In addition, MVision also offered a clinical staff training platform to facilitate the delineation of OARs according to the established clinical guidelines.
Empirical evaluation According to the feedback provided by the radiographers, the main issues were under- or over-segmentation of the optic nerve and chiasm (cf. last example in the first row in Fig. 2), as well as of the spinal cord and brainstem (cf. third row in Fig. 2). Moreover, they also pointed out how the presence of dental artifacts, mouth bites and tumors affected the auto-segmentation accuracy of the mandible and oral cavity (cf. second row in Fig. 2). Radiographers also noted discrepancies in the auto-segmentation of the parotid glands in the lateral direction (cf. first row in Fig. 2).
Fig. 2.
Visualization of the reference and AI-generated contours, showing axial slices from the same patient (top row), three patients with dental artifacts and three with mouth bites (middle row, left to right), and mid-sagittal slices from different patients (bottom row). Red arrows highlight substantial deviations between reference and AI-generated contours.
Analytical evaluation
Geometric evaluation The geometric performance of the AI-generated contours, assessed against curated reference segmentations for 13 OARs available across all three software solutions, is summarized in Table 2 and visualized in Figs. 3 and 4. Overall, Limbus achieved the highest mean DSC (69.7%), followed by MIM (69.2%) and MVision (66.7%). In terms of HD95, Limbus also performed best (lowest average value of 5.0 mm), followed by MVision (5.3 mm) and MIM (5.6 mm). Statistical significance was assessed using the Wilcoxon signed-rank test with Bonferroni correction, with the per-OAR results shown in Fig. 3. For the overall performance, statistically significant differences in DSC were observed only between Limbus and MVision (marginal, p = 0.048), while in HD95 they were observed between MIM and MVision (p = 0.009) as well as between Limbus and MVision (p = 0.032). High DSC values (≥ 80%) were achieved for the brainstem, mandible, parotid glands, submandibular glands, and thyroid gland, while a notably low performance was observed for the optic chiasm (DSC < 50%), especially for MIM (Fig. 4). Statistically significant differences in DSC were observed for the brainstem, cochleae, optic chiasm, oral cavity, parotid glands, pituitary, spinal cord, and thyroid gland. For HD95, the best performance was noted for the cochleae, mandible, pituitary gland, spinal cord, and thyroid gland (HD95 < 4 mm), whereas the oral cavity showed the poorest performance (HD95 > 8 mm). Statistically significant differences in HD95 were found for the brainstem, left cochlea, parotid glands, and thyroid gland.
Table 2.
Results of geometric and psychometric evaluations, reported as mean ± standard deviation for each organ-at-risk (OAR), as well as aggregated by artifact group and overall. Best results are typeset in bold.
| OAR | DSC (%) | HD95 (mm) | Likert scale ratings | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Limbus | MIM | MVision | Limbus | MIM | MVision | Limbus | MIM | MVision | |
| Brainstem | 82.6 ± 5.6 | 81.2 ± 4.6 | 79.4 ± 5.6 | 5.2 ± 3.5 | 6.5 ± 3.2 | 6.0 ± 3.3 | 3.9 ± 0.5 | 3.5 ± 0.4 | 3.5 ± 0.3 |
| Cochlea (L) | 50.7 ± 10.3 | 66.3 ± 8.3 | 50.0 ± 15.9 | 1.9 ± 0.5 | 1.6 ± 0.5 | 2.1 ± 0.5 | 3.6 ± 0.5 | 3.9 ± 0.6 | 3.6 ± 0.4 |
| Cochlea (R) | 51.2 ± 18.5 | 66.4 ± 9.3 | 52.7 ± 14.8 | 2.2 ± 0.8 | 1.9 ± 0.5 | 2.1 ± 0.4 | 3.5 ± 0.4 | 3.8 ± 0.5 | 3.6 ± 0.2 |
| Lacrimal gland (L) | 53.6 ± 12.0 | 48.9 ± 14.7 | 53.1 ± 12.0 | 4.3 ± 2.6 | 4.9 ± 3.0 | 4.5 ± 2.5 | |||
| Lacrimal gland (R) | 49.5 ± 15.2 | 45.4 ± 12.6 | 51.3 ± 16.4 | 4.8 ± 2.6 | 4.7 ± 1.8 | 4.9 ± 2.8 | |||
| Lips | 66.6 ± 5.8 | 70.0 ± 6.8 | 67.0 ± 7.4 | 8.2 ± 2.5 | 6.3 ± 1.2 | 8.5 ± 2.8 | |||
| Mandible | 92.7 ± 2.0 | 92.3 ± 2.0 | 92.1 ± 1.7 | 1.5 ± 0.7 | 2.2 ± 1.0 | 1.5 ± 0.5 | 3.6 ± 0.6 | 3.0 ± 0.2 | 3.6 ± 0.6 |
| Optic chiasm | 41.2 ± 9.2 | 26.7 ± 21.9 | 18.7 ± 12.2 | 5.5 ± 1.2 | 6.1 ± 1.8 | 6.5 ± 0.8 | 3.6 ± 0.5 | 1.5 ± 0.6 | 3.2 ± 0.4 |
| Optic nerve (L) | 65.6 ± 13.0 | 64.3 ± 12.4 | 62.7 ± 10.2 | 5.4 ± 4.0 | 7.8 ± 4.9 | 5.6 ± 4.3 | 4.5 ± 0.7 | 4.1 ± 0.4 | 4.3 ± 0.8 |
| Optic nerve (R) | 69.1 ± 7.5 | 65.1 ± 7.5 | 64.8 ± 8.4 | 4.3 ± 4.1 | 7.5 ± 4.8 | 6.8 ± 6.2 | 4.5 ± 0.6 | 4.4 ± 0.4 | 4.3 ± 0.6 |
| Oral cavity | 79.8 ± 8.1 | 85.0 ± 6.1 | 82.4 ± 8.1 | 12.7 ± 7.0 | 9.0 ± 4.4 | 11.3 ± 6.6 | |||
| Parotid gland (L) | 82.5 ± 3.8 | 77.6 ± 7.1 | 82.8 ± 4.2 | 6.6 ± 2.4 | 10.9 ± 6.9 | 7.2 ± 3.4 | 4.0 ± 0.3 | 3.4 ± 0.5 | 4.0 ± 0.6 |
| Parotid gland (R) | 82.9 ± 5.4 | 74.9 ± 9.8 | 83.0 ± 6.2 | 5.6 ± 1.3 | 11.6 ± 6.8 | 6.7 ± 4.1 | 3.9 ± 0.5 | 3.5 ± 0.5 | 3.8 ± 0.5 |
| Pituitary gland | 64.6 ± 15.5 | 52.6 ± 14.2 | 35.8 ± 13.8 | 3.1 ± 1.5 | 3.2 ± 1.2 | 3.9 ± 1.3 | |||
| Spinal cord | 75.6 ± 4.9 | 77.5 ± 3.5 | 78.3 ± 6.0 | 3.4 ± 1.8 | 3.3 ± 1.1 | 2.9 ± 1.3 | 4.0 ± 0.4 | 3.8 ± 0.5 | 3.4 ± 0.4 |
| Submandibular gland (L) | 81.5 ± 4.8 | 83.1 ± 8.0 | 82.8 ± 5.6 | 5.3 ± 3.3 | 4.6 ± 2.7 | 5.1 ± 2.8 | |||
| Submandibular gland (R) | 80.0 ± 10.6 | 80.2 ± 8.4 | 79.9 ± 10.0 | 5.4 ± 4.5 | 5.5 ± 3.2 | 5.6 ± 4.8 | |||
| Thyroid gland | 84.2 ± 5.4 | 87.6 ± 4.4 | 84.3 ± 4.4 | 3.7 ± 3.5 | 3.6 ± 3.5 | 4.5 ± 3.3 | |||
| Normal | 68.1 ± 18.3 | 67.9 ± 20.4 | 64.9 ± 21.8 | 5.9 ± 4.7 | 6.2 ± 5.6 | 6.1 ± 3.7 | 4.0 ± 0.5 | 3.6 ± 1.0 | 3.7 ± 0.5 |
| Mouth bite | 70.3 ± 16.8 | 69.1 ± 19.0 | 67.0 ± 21.9 | 4.7 ± 3.8 | 6.0 ± 4.3 | 5.5 ± 5.1 | 3.8 ± 0.5 | 3.5 ± 0.9 | 3.7 ± 0.6 |
| Artifacts | 70.3 ± 17.4 | 70.2 ± 18.4 | 68.0 ± 21.1 | 4.4 ± 3.0 | 4.8 ±3.1 | 4.6 ± 3.1 | 3.9 ± 0.6 | 3.5 ± 0.8 | 3.8 ± 0.6 |
| Overall | 69.7 ± 17.4 | 69.2 ± 19.1 | 66.7 ± 21.5 | 5.0 ± 3.9 | 5.6 ± 4.4 | 5.3 ± 4.0 | 3.9 ± 0.6 | 3.5 ± 0.9 | 3.7 ± 0.6 |
Likert scale: 1 – unusable, 2 –major edits required, 3 – minor edits that are necessary, 4 – minor edits that are not necessary, 5 – clinically acceptable.
L: left; R: right.
Fig. 3.
Box plots of the Dice similarity coefficient (DSC), Hausdorff distance (HD95), and average Likert ratings for different organs-at-risk, comparing the three AI software. Asterisks indicate statistically significant differences between AI software based on the Wilcoxon paired signed-rank test with Bonferroni correction (∗ → 0.05 > p > 0.01; ∗∗ → 0.01 > p > 0.001).
Fig. 4.
Visual analysis of the relationships between different types of metrics, reported separately for each organ-at-risk (one per row). The first two columns show scatter plots comparing the average Likert rating (horizontal axis) with two geometric metrics (vertical axis): Dice similarity coefficient (DSC) and 95th percentile Hausdorff distance (HD95). The third column illustrates the inter-rater agreement between the two Likert scale raters.
It has to be noted that, due to the variability in the cranial and caudal limits between curated and AI-generated brainstem and spinal cord contours, to ensure a fair comparison the brainstem auto-segmentations were truncated at the caudal end of the curated mask, while the spinal cord auto-segmentations were truncated at both cranial and caudal ends. A similar approach that focuses on the geometric agreement rather than the effects of different contouring guidelines has been also adopted in previous studies16,38. Moreover, although the AI-generated contours were compared against curated contours defined by a single observer43, the estimated overall inter-observer variability of delineating OARs from the same dataset (i.e. DSC of 71.2%, HD95 of 4.9 mm)16 was similar to the results obtained by the three software solutions, indicating that they perform at the level of human experts.
Dosimetric evaluation The results of the compliance with dosimetric constraints are presented in Table 3 and Fig. 4. Overall compliance rates were similar across the three software solutions, with Limbus, MIM, and MVision achieving compliance in 70.5%, 70.0%, and 71.2% of cases, respectively. The highest compliance was achieved for the brainstem, cochleae, lacrimal glands, optic chiasm, optic nerves, and pituitary gland, while the lowest compliance was observed for the oral cavity and submandibular glands. In terms of the priority-based assessment, 5 out of 10 test cases met the highest-priority constraints (P1) with Limbus and MIM, while 6 cases did so with MVision. For the P4 constraints, 4, 2, and 3 cases met the criteria with Limbus, MIM, and MVision, respectively. Notably, none of the software solutions satisfied all dosimetric constraints for all OARs within the same patient.
Table 3.
The number of AI-generated contours (out of a total of 10) that meet the dosimetric constraints for a selected organ-at-risk (OAR) (top), and the number of cases meeting different priority levels PL (bottom). The gross tumor volume (GTV), clinical target volume (CTV) and planning target volume (PTV) verifications are included for completeness but are outside the scope of this study (/). The eyeball auto-segmentations were not available for all AI software and are thus left of out the analysis (top). Each priority level encompasses the preceding ones, therefore the reported number of cases (bottom) decreases with the increasing priority level.
| OAR | Dosimetric constraint | Limbus | MIM | MVision |
|---|---|---|---|---|
| No. cases meeting dose constraints | ||||
| Brainstem | VEQD 54 Gy < 1% | 10 | 10 | 10 |
| Cochlea (L) | Dmean < 45 Gy | 8 | 8 | 8 |
| Cochlea (R) | 9 | 9 | 9 | |
| Lacrimal gland (L) | Dmean ≤ 30 Gy | 10 | 10 | 10 |
| Lacrimal gland (R) | 9 | 9 | 9 | |
| Lips | Dmax < 50 Gy | 6 | 5 | 5 |
| Mandible | V70 Gy < 1 ccm | 6 | 6 | 6 |
| Optic chiasm | EQDmax < 54 Gy | 9 | 10 | 10 |
| Optic nerve (L) | EQDmax < 54 Gy | 9 | 10 | 10 |
| Optic nerve (R) | 9 | 9 | 9 | |
| Oral cavity | Dmax < 50 Gy | 1 | 1 | 1 |
| Parotid gland (L) | Dmean < 26 Gy/Dmedian < 30 Gy | 6 | 6 | 6 |
| Parotid gland (R) | 9 | 7 | 8 | |
| Pituitary gland | V65 Gy < 1% | 8 | 8 | 8 |
| Spinal cord | EQDmax < 50 Gy & V45 Gy < 1 ccm | 6 | 6 | 7 |
| Submandibular gland (L) | Dmean ≤ 35 Gy | 3 | 3 | 3 |
| Submandibular gland (R) | 2 | 2 | 2 | |
| Percentage of OARs meeting dosimetric constraints | 70.5% | 70.0% | 71.2% | |
| Priority level | No. cases meeting priority constraints | |||
|---|---|---|---|---|
| P1: spinal cord, brainstem, optic chiasm, optic nerves | 5 | 5 | 6 | |
| P2: P1 + GTV, CTV | / | / | / | |
| P3: P2 + PTV, eyeballs | / | / | / | |
| P4: P3 + parotids, cochleae | 4 | 2 | 3 | |
| P5: P4 + all OARs | 0 | 0 | 0 | |
L: left; R: right.
Psychometric evaluation The Likert scale ratings of two radiographers demonstrated good intra-rater agreement, with Kendall’s τ coefficients of 0.76 (p = 0.022) for radiographer 1 and 0.84 (p = 0.004) for radiographer 2. In contrast, the inter-rater agreement shown in Fig. 4 was lower, with τ of 0.45 (p = 0.001). Overall, Limbus received the highest mean rating (3.9) followed by MVision (3.7) and MIM (3.5) (Table 2). In terms of clinical usability, 100%, 90%, and 97% segmentations received an average Likert rating ≥ 3 and 57%, 51%, and 50% a rating ≥ 4 for Limbus, MIM, and MVision, respectively. Strong statistical differences were observed between Limbus and MIM (p = 0.0001), and less strong between Limbus and MVision (p = 0.049) as well as between MVision and MIM (p = 0.024). Across all three software solutions, the optic nerves received the highest mean Likert ratings, while the optic chiasm received the lowest. Statistically significant per-OAR differences between the three software solutions were observed for the mandible and optic chiasm, with the largest discrepancies noted for the latter.
Relationships between metrics The relationships between geometric and psychometric evaluation, stratified by OARs, AI software solutions, and dosimetric compliance, are visually presented in Fig. 4. A more general visualization across all OARs and AI software solutions is shown in Fig. 5, indicating that no correlation exists among the geometric metrics and average Likert ratings across all OARs. These observations were confirmed using the Pearson and Spearman coefficients, which consistently yielded low values (< 0.1) for all comparisons conducted across all OARs and all AI software solutions.
Fig. 5.
Scatter plots showing the relationship between the distance from the organ-at-risk to the target tissue and various metrics, including Dice similarity coefficient (DSC), 95th percentile Hausdorff distance (HD95), average Likert rating, average dose (Dmean) and maximal dose (Dmax). (Note: Jitter was added to average Likert ratings to enhance readability).
Discussion
A review of the literature revealed that studies comparing commercial AI software solutions often focus on a limited set of evaluations (typically one or a few), and rarely conduct comprehensive observational and analytical assessments (Table 1). However, evaluating these solutions from multiple perspectives is essential, given the complexity of clinical workflows, which demand regulatory compliance, stringent data security, seamless integration with existing hospital systems, intuitive user interfaces, and robust performance that genuinely accelerates the RT planning process. Due to the sequential nature of RT planning, the least optimal step can eventually become a bottleneck, ultimately determining the efficiency of the entire workflow. Comprehensive multi-perspective evaluations are therefore crucial, and to this end, we systematically analyzed three AI software solutions from the observational (using descriptive and empirical evaluations) and analytical (using geometric, dosimetric, and psychometric evaluations) perspective (Fig. 1).
Observational evaluation
Findings from the questionnaire did not reveal any major differences between the three AI software solutions in terms of certification, data interoperability, or underlying methodologies. Limbus is the only software solution that does not offer a cloud-based storage; however, this is not a critical limitation, as strict regulations often require hospital-based storage. Differences were observed in the level of customization available for contouring standards – both Limbus and MVision support the development of proprietary hospital models – while a greater variability was noted in the number of supported OARs, with MVision covering the most (32) and MIM the least (18) OARs for the HaN region. All software companies are actively working to expand their functionality, including support for additional OARs, lymph node segmentation, and delineation on cone beam CT (CBCT) and MR images. However, none currently supports multimodal segmentation that combines CT and MR images, despite their common use in HaN RT planning43,58.
In line with the European Medical Device Regulation (MDR)59, post-market surveillance is required for all clinically used software. All software companies provide quantitative tools for comparing AI-generated with reference contours, however, none currently offers annotation functionalities that would allow users to flag discrepancies for continuous model refinement. This limitation reflects a broader challenge in data governance: strict regulations and institutional policies often constrain data sharing between clinical centers and AI developers, impeding the iterative improvement of AI algorithms. Addressing this sensitive issue requires the development of secure, ethical, and consent-driven data-sharing frameworks. Such frameworks would enable active refinement of AI models, particularly benefiting patients at deployment sites, but would also require collaboration between regulatory, medical, and technical stakeholders.
Analytical evaluation
The geometric evaluation highlights the well-known observation of the volume dependency of the DSC metric, where smaller organs tend to have lower DSC scores23,43,60–64. This underscores the complementary value of boundary-based metrics such as HD95 in assessing the geometric performance. For example, although cochleae auto-segmentations produced by Limbus achieved a DSC of just over 50%, the corresponding HD95 was around 2 mm, and Likert ratings indicated that only minor or no edits were needed (average Likert rating of 3.6). A similar pattern was observed for the optic nerves, which scored a moderate DSC of around 65% and an HD95 of approximately 5.0 mm. Despite these relatively poor geometric scores, the optic nerves achieved the highest Likert ratings, which clearly demonstrates that geometric metrics alone offer only a limited insight into the clinical usability of OAR contours. A strong overall geometric performance was achieved for the mandible (DSC > 90%, HD95 < 2 mm), however, this did not translate into an equally strong dosimetric compliance (only 50% for both MIM and MVision) or qualitative ratings (relatively moderate Likert rating of 3.6). This mismatch is most likely due to the impact of dental artifacts and mouth bites, which, as noted by raters, can confuse the AI models (cf. second row, fifth column in Fig. 2). When comparing the geometric performance among AI software solutions, the most pronounced differences were found in smaller OARs such as the cochleae, lacrimal glands, optic chiasm, and pituitary gland. Interestingly, these geometric differences were less reflected in the dosimetric results and qualitative scores. With the exception of poor ratings for the optic chiasm and excellent ones for the optic nerves, the Likert ratings for the remaining OARs generally ranged between 3 and 4, suggesting only minor revisions were necessary.
Nonetheless, the Likert ratings of the two radiographers presented in the third column in Fig. 4 also highlight the subjectivity of qualitative evaluation. Low inter-rater agreement was particularly notable at the higher end of the scale (ratings ≥ 3), where the first rater appeared more inclined to give scores of 4 or 5 compared to the second one. At the lower end of the scale (ratings ≤ 2), both raters showed better alignment (cf. optic chiasm in Fig. 4). Notably, since Likert ratings were overall skewed toward higher points, this observation may not be statistically robust.
In terms of dosimetric compliance, small OARs generally performed very well. This can be explained by the fact that small boundary deviations – while impactful in geometric terms – rarely translate into significant dosimetric changes. However, this does not apply universally, as the proximity to the target volume and the resulting steep dose gradients can also result in large dosimetric deviations. Conversely, the oral cavity and submandibular glands performed poorly from this perspective. The obtained results are consistent with observations of Koo et al.51 and are most likely attributable to two factors: the presence of mouth bites and thus inaccurate segmentations (Fig. 2) and proximity to the tumor (cf. first row in Fig. 5), which result in steep dose gradients where even small geometric errors can lead to large dosimetric deviations, especially given that these OARs are not small. The priority-based analysis further suggests that AI software solutions are not yet ready for a fully autonomous use without expert review. In most cases where P1 constraints were not met, the cause was related to spinal cord auto-segmentations. We hypothesize this was due to over-contouring of this structure, as this issue was also noted by the two radiographers. An alternative explanation could be the lack of clearly defined anatomical boundaries between the spinal cord and brainstem, or the presence of differences in contouring practice regarding the cranial extent of the spinal cord. However, this effect was most likely mitigated by the applied cropping of the AI-generated contours based on the reference cranial and caudal limits, making the over-contouring more likely the primary issue (under-contouring is rather unlikely, as P1 constraints are based on Dmax and volume thresholds, and not on Dmean).
To study the relationships among the triangle of analytical metrics (Fig. 1) – geometric, dosimetric, and psychometric – we performed an analysis across all OARs and AI software solutions (Fig. 5), and found no clear correlations or monotonic trends. While this could be due to the limited number of cases or low inter-rater agreement, our results suggest that the search for a universal proxy metric to replace expert evaluation or dosimetric assessment may be futile65. Notably, previous studies have already shown weak or no correlation between geometric and dosimetric metrics52,61,66–69, and it this study we additionally show that linking either to Likert ratings is similarly non-trivial. The contrast between the optic chiasm and optic nerves illustrates this well. That said, if any relationships exist, they are most likely OAR-specific. For example, Fig. 4 suggests a stronger metric coherence when analyses are performed per-OAR or across groups of similar structures (e.g. by volume or proximity to the target). This hypothesis, however, requires a more thorough validation on a larger cohort. Moreover, it has to be noted that while we evaluated the geometric performance with DSC and HD95, other metrics such as those derived from the radiomic features50 may be used to provide additional information about the segmentation quality and can be used as a valuable supplement, especially from the perspective of identifying regions of poor or incorrect contouring. Similarly, the dosimetric performance may be evaluated with the emerging field of dosiomics53 that focuses on extracting radiomic features from dose distributions maps and, in contrast to standard dosimetric metrics, preserves the spatial information about the dose. However, such analyses extend beyond the standard benchmarks of RT workflows, but may be considered for future work.
Comparison to existing studies
For the studies presented in Table 1, the comparison of the geometric, dosimetric and psychometric performance across studies is reported in Supplementary Material, respectively in Tables S2, S3 and S4. The comparison of the geometric performance in terms of DSC and HD95 (Table S2) indicates that, in general, our results are similar to those reported by existing studies, as the difference is often within ± 5%pt and ± 5 mm, respectively. Apart from a few exceptions, such as the results of D’Aviero et al.19, who reported extremely good performance for practically all OARs, the results of Hoque et al.25, who reported relatively poor performance for cochleae, parotid glands and submandibular glands, or the results of Chen et al.27, who reported poor performance for the spinal cord, most studies reported similar DSC and HD95 for specific OARs. A similar conclusion can be drawn for the comparison of the dosimetric performance (Table S3), where the dose differences are in general in the same order of magnitude, except for the results of Chen et al.27 in the case of lacrimal glands, the mandible and parotid glands, and the results of Sarria et al.35 in the case of lips, where the deviations are larger than those reported by other studies. Finally, the comparison of the psychometric performance (Table S4) indicates that Likert ratings are well aligned across all studies for all observed OARs, except for the results of Hu et al.26, who reported a considerably lower average rating for the mandible. It has to be noted that different studies evaluated the software solutions on different datasets, moreover, commercial software solutions improve with time, with updated versions being continuously released, which introduces bias in such performance comparisons. Nevertheless, as our analyses were performed on a publicly available dataset, i.e. the HaN-Seg dataset43, the obtained results may represent a reference benchmark for eventual future evaluations of segmentation software for OARs in the HaN region.
Limitations and future work
One of the limitations of this study is that the image subset may not fully represent the variability in patient anatomies, pathologies, or tumor locations, which could impact algorithm robustness in broader clinical use. While we included cases with diverse clinical challenges to mitigate this issue (i.e. mouth bites and artifacts), additional experiments on datasets spanning different demographics, CT scanners, and clinical conditions are needed to generalize such findings27,39. Another limitation is the use of forward dosimetric analysis51, which does not capture the full impact of auto-segmentation on RT planning in comparison to performing a full replanning. However, access to RT planning infrastructure was unavailable, and prior work by van Aalst et al.52 supports forward analysis as a valid and scalable alternative. An inherent limitation of this type of study is that the results reflect the performance of AI models at the time of evaluation. As software companies continue to improve algorithms with expanded training data and user feedback, ongoing performance monitoring remains essential. Future work could address some of these limitations, explore AI auto-segmentation of lymph nodes, and extend the evaluation framework to other anatomical sites and imaging modalities (e.g. CBCT and MR).
Conclusions
Observational evaluation confirmed that all three AI software solutions comply with key regulatory requirements, including rigorous annotation, peer review, and validation processes to ensure segmentation quality. The main comparative differences were observed in the number of supported OARs and the flexibility to adapt segmentation styles to local clinical standards. All software companies are actively advancing their models by incorporating more data and expanding support for additional OARs, lymph nodes, and imaging modalities. The analytical evaluation compared AI auto-segmentations to manually generated reference contours using a triad of metrics: geometric, dosimetric, and psychometric. While overall differences among software solutions were modest, statistically significant differences were observed for certain OARs. Psychometric assessment with Likert ratings indicated that the majority of auto-segmentations were of reasonably good quality. However, manual editing was often indicated for clinical acceptability, particularly for complex structures like the optic chiasm, or in challenging scenarios involving imaging artifacts, the proximity of tumors to OARs, and the presence of mouth bites. Importantly, no clear correlation was observed among geometric, dosimetric, and psychometric metrics, underscoring the limited redundancy among them and highlighting the value of multi-perspective evaluation frameworks.
Supplementary Information
Below is the link to the electronic supplementary material.
Acknowledgements
The authors thank the software companies Limbus AI (part of Radformation Inc.), MIM Software Inc. (part of GE HealthCare Inc.) and MVision AI for their participation.
Abbreviations
- AI
Artificial intelligence
- CT
Computed tomography
- CNN
Convolutional neural network
- DSC
Dice similarity coefficient
- HD
Hausdorff distance
- HD95
Hausdorff distance, 95th percentile
- HaN
Head and neck
- IMRT
Intensity modulated radiation therapy
- MR
Magnetic resonance
- OAR
Organ-at-risk
- RT
Radiotherapy
- VMAT
Volumetric modulated arc therapy
Author contributions
GP, CB, SM and TV contributed to the study design. SM collected the data, GP and CB performed the experiments and statistical analysis, and CJD, SM and TV interpreted the results. All authors read and approved the final manuscript.
Funding
This work was funded by the Ministry for Education, Sport, Youth, Research and Innovation in Malta under the Tertiary Education Scholarship Scheme (TESS), and by the Slovenian Research and Innovation Agency (ARIS) under grants P2-0232 and J2-60042.
Data availability
The HaN-Seg dataset43 is publicly available online (https://doi.org/10.5281/zenodo.7442913). The cases used in this study are available from the corresponding author upon reasonable request.
Declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Footnotes
Additional Information
The original online version of this Article was revised: The original version of this Article contained an error in Figure 2, where the entire figure was duplicated on the next page.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally and share the first authorship: Gašper Podobnik and Clarissa Borg.
Change history
11/4/2025
A Correction to this paper has been published: 10.1038/s41598-025-26873-6
References
- 1.Vaassen, F. et al. Evaluation of measures for assessing timesaving of automatic organ-at-risk segmentation in radiotherapy. Phys. Imaging Radiat. Oncol.13, 1–6. 10.1016/j.phro.2019.12.001 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Vrtovec, T., Močnik, D., Strojan, P., Pernuš, F. & Ibragimov, B. Auto-segmentation of organs at risk for head and neck radiotherapy planning: from atlas-based to deep learning methods. Med. Phys.47, e929–e950. 10.1002/mp.14320 (2020). [DOI] [PubMed] [Google Scholar]
- 3.De Biase, A. et al. Clinical adoption of deep learning target auto-segmentation for radiation therapy: challenges, clinical risks, and mitigation strategies. BJR Artif. Intel. 1, ubae015. 10.1093/bjrai/ubae015 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Delaby, N. et al. Practical and technical key challenges in head and neck adaptive radiotherapy: the GORTEC point of view. Phys. Med.109, 102568. 10.1016/j.ejmp.2023.102568 (2023). [DOI] [PubMed] [Google Scholar]
- 5.Yu, X-L. et al. Real-time morphological and dosimetric adaptation in nasopharyngeal carcinoma radiotherapy: insights from autosegmented fractional fan-beam CT. Radiat. Oncol.20, 68. 10.1186/s13014-025-02643-6 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Mastella, E. et al. A systematic review of the role of artificial intelligence in automating computed tomography-based adaptive radiotherapy for head and neck cancer. Phys. Imaging Radiat. Oncol.33, 100731. 10.1016/j.phro.2025.100731 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Bibault, J-E. & Giraud, P. Deep learning for automated segmentation in radiotherapy: a narrative review. Br. J. Radiol.97, 13–20. 10.1093/bjr/tqad018 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ronneberger, O., Fischer, P. & Brox, T. U-Net: Convolutional networks for biomedical image segmentation. In: 18th International Conference on Medical Image Computing and Computer Assisted Intervention – MICCAI 2015, Springer, Lecture Notes in Computer Science, vol. 9351, pp. 234–241, (2015). 10.1007/978-3-319-24574-4_28
- 9.Isensee, F., Jaeger, P., Kohl, S., Petersen, J. & Maier-Hein, K. nnU-Net: A self-configuring method for deep learning-based biomedical image segmentation. Nat. Methods. 18, 203–211. 10.1038/s41592-020-01008-z (2021). [DOI] [PubMed] [Google Scholar]
- 10.Wasserthal, J. et al. TotalSegmentator: robust segmentation of 104 anatomic structures in CT images. Radiol. Artif. Intell.5, e230024. 10.1148/ryai.230024 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Shen, Y. et al. FastSAM3D: An efficient segment anything model for 3D volumetric medical images. In 27th International Conference on Medical Image Computing and Computer Assisted Intervention – MICCAI 2024, Springer, Lecture Notes in Computer Science, vol. 15012, pp. 542–552, (2024). 10.1007/978-3-031-72390-2_51 [DOI] [PMC free article] [PubMed]
- 12.Xu, G. et al. A segment anything model-guided and match-based semi-supervised segmentation framework for medical imaging. Med. Phys.52, 4513–4527. 10.1002/mp.17785 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Rong, Y. et al. NRG oncology assessment of artificial intelligence deep learning-based auto-segmentation for radiation therapy: current developments, clinical considerations, and future directions. Int. J. Radiat. Oncol. Biol. Phys.119, 261–280. 10.1016/j.ijrobp.2023.10.033 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Can Erdur, A. et al. Deep learning for autosegmentation for radiotherapy treatment planning: state-of-the-art and novel perspectives. Strahlenther Onkol. 201, 236–254. 10.1007/s00066-024-02262-2 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Guzene, L. et al. Assessing interobserver variability in the delineation of structures in radiation oncology: a systematic review. Int. J. Radiat. Oncol. Biol. Phys.115, 1047–1060. 10.1016/j.ijrobp.2022.11.021 (2023). [DOI] [PubMed] [Google Scholar]
- 16.Podobnik, G., Ibragimov, B., Peterlin, P. & Strojan, P. Vrtovec. vOARiability: interobserver and intermodality variability analysis in OAR contouring from head and neck CT and MR images. Med. Phys.51, 2175–2186. 10.1002/mp.16924 (2024). [DOI] [PubMed] [Google Scholar]
- 17.Nielsen, C. et al. Interobserver variation in organs at risk contouring in head and neck cancer according to the DAHANCA guidelines. Radiother Oncol.197, 110337. 10.1016/j.radonc.2024.110337 (2024). [DOI] [PubMed] [Google Scholar]
- 18.Atasoy, B. M. et al. The role of radiotherapy planning images in monitoring malnutrition and predicting prognosis in head and neck cancer patients: a pilot study. Radiat. Oncol.20, 70. 10.1186/s13014-025-02645-4 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.D’Aviero, A. et al. Clinical validation of a deep-learning segmentation software in head and neck: an early analysis in a developing radiation oncology center. Int. J. Environ. Res. Public. Health. 19, 9057. 10.3390/ijerph19159057 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Hobbis, D. et al. ASTRO annual 2022 meeting: comparisons of clinical and reference standard contours to AI auto-segmentation: an evaluation of 5 commercial models in head and neck organ at risk delineation. Int. J. Radiat. Oncol. Biol. Phys.114, e98. 10.1016/j.ijrobp.2022.07.888 (2022). [Google Scholar]
- 21.Radici, L. et al. Implementation of a commercial deep learning-based auto segmentation software in radiotherapy: evaluation of effectiveness and impact on workflow. Life (Basel). 12, 2088. 10.3390/life12122088 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Anaya, V. M. Artificial intelligence based auto-contouring solutions for use in radiotherapy treatment planning of head and neck cancer. IPEM Transl6, 100018. 10.1016/j.ipemt.2023.100018 (2023). [Google Scholar]
- 23.Doolan, P. J. et al. A clinical evaluation of the performance of five commercial artificial intelligence contouring systems for radiotherapy. Front. Oncol.13, 1213068. 10.3389/fonc.2023.1213068 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Heilemann, G. et al. Clinical implementation and evaluation of auto-segmentation tools for multi-site contouring in radiotherapy. Phys. Imaging Radiat. Oncol.28, 100515. 10.1016/j.phro.2023.100515 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hoque, S. M. H. et al. Clinical use of a commercial artificial intelligence-based software for autocontouring in radiation therapy: geometric performance and dosimetric impact. Cancers (Basel). 15, 5735. 10.3390/cancers15245735 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Hu, Y. et al. Clinical assessment of a novel machine-learning automated contouring tool for radiotherapy planning. J. Appl. Clin. Med. Phys.24, e13949. 10.1002/acm2.13949 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Chen, L. et al. Validation of a deep-learning segmentation model for adult and pediatric head and neck radiotherapy in different patient positions. Phys. Imaging Radiat. Oncol.29, 100527. 10.1016/j.phro.2023.100527 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Johnson, C. L. et al. Simone 2nd CB,. Clinical validation of commercial deep-learning based auto-segmentation models for organs at risk in the head and neck region: a single institution study. Front Oncol. ;14:1375096. (2024). 10.3389/fonc.2024.1375096 [DOI] [PMC free article] [PubMed]
- 29.Kim, Y. W., Biggs, S. & Claridge Mackonis, E. Investigation on performance of multiple AI-based auto-contouring systems in organs at risks (OARs) delineation. Phys. Eng. Sci. Med.47, 1123–1140. 10.1007/s13246-024-01434-9 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lê, A. T. et al. Head and neck automatic multi-organ segmentation on dual-energy computed tomography. Phys. Imaging Radiat. Oncol.32, 100654. 10.1016/j.phro.2024.100654 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Luan, S. et al. Accurate and robust auto-segmentation of head and neck organ-at-risks based on a novel CNN fine-tuning workflow. J. Appl. Clin. Med. Phys.25, e14248. 10.1002/acm2.14248 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Maes, D. et al. Framework for radiation oncology department-wide evaluation and implementation of commercial artificial intelligence autocontouring. Pract. Radiat. Oncol.14, e150–e158. 10.1016/j.prro.2023.10.011 (2024). [DOI] [PubMed] [Google Scholar]
- 33.Mody, P. et al. Large-scale dose evaluation of deep learning organ contours in head-and-neck radiotherapy by leveraging existing plans. Phys. Imaging Radiat. Oncol.30, 100572. 10.1016/j.phro.2024.100572 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Moktan, H. et al. ASTRO annual 2024 meeting: evaluating commercial auto-segmentation software generated contours on MRI and their clinical acceptability for cranial stereotactic radiosurgery. Int. J. Radiat. Oncol. Biol. Phys.120, e167. 10.1016/j.ijrobp.2024.07.376 (2024). [Google Scholar]
- 35.Sarria, G. R. et al. Artificial intelligence–based autosegmentation: advantages in delineation, absorbed dose-distribution, and logistics. Adv. Radiat. Oncol.9, 101394. 10.1016/j.adro.2023.101394 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Temple, S. W. P. & Rowbottom, C. G. Gross failure rates and failure modes for a commercial AI-based auto-segmentation algorithm in head and neck cancer patients. J. Appl. Clin. Med. Phys.25, e14273. 10.1002/acm2.14273 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Way, S. M. et al. ASTRO annual 2024 meeting: physician assessment and clinical evaluation of the suitability of deep learning based auto segmentation contours for organs at risk delineation in radiation oncology. Int. J. Radiat. Oncol. Biol. Phys.120, e594. 10.1016/j.ijrobp.2024.07.1309 (2024). [Google Scholar]
- 38.Finnegan, R. N. et al. Geometric and dosimetric evaluation of a commercial AI auto-contouring tool on multiple anatomical sites in CT scans. J. Appl. Clin. Med. Phys.26, e70067. 10.1002/acm2.70067 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Rusanov, B. et al. Guidance on selecting and evaluating AI auto-segmentation systems in clinical radiotherapy: insights from a six-vendor analysis. Phys. Eng. Sci. Med.48, 301–316. 10.1007/s13246-024-01513-x (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Sharma, D. et al. Geometric and dosimetric evaluation of a raystation deep learning model for auto-segmentation of organs at risk in a real-world head and neck cancer dataset. Clin. Oncol.41, 103796. 10.1016/j.clon.2025.103796 (2025). [DOI] [PubMed] [Google Scholar]
- 41.Lee, A. et al. International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys.105, 567–580. 10.1016/j.ijrobp.2019.06.2540 (2019). [DOI] [PubMed] [Google Scholar]
- 42.Jensen, K. et al. The Danish head and neck cancer group (DAHANCA) 2020 radiotherapy guidelines. Radiother Oncol.151, 149–151. 10.1016/j.radonc.2020.07.037 (2020). [DOI] [PubMed] [Google Scholar]
- 43.Podobnik, G. et al. The head and neck organ-at-risk CT and MR segmentation dataset. Med. Phys.50, 1917–1927. 10.1002/mp.16197 (2024). [DOI] [PubMed] [Google Scholar]
- 44.Brouwer, C. et al. CT-based delineation of organs at risk in the head and neck region:dahanca, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG oncology and TROG consensus guidelines. Radiother Oncol.117, 83–90. 10.1016/j.radonc.2015.07.041 (2015). [DOI] [PubMed] [Google Scholar]
- 45.Podobnik, G. et al. HaN-Seg: the head and neck organ-at-risk CT and MR segmentation challenge. Radiother Oncol.198, 110410. 10.1016/j.radonc.2024.110410 (2024). [DOI] [PubMed] [Google Scholar]
- 46.Selles, M., van Osch, K. A. C., Maas, M., Boomsma, M. F. & Wellenberg, R. H. H. Advances in metal artifact reduction in CT images: a review of traditional and novel metal artifact reduction techniques. Eur. J. Radiol.170, 111276. 10.1016/j.ejrad.2023.111276 (2024). [DOI] [PubMed] [Google Scholar]
- 47.Podobnik, G. & Vrtovec, T. Metrics revolutions: Groundbreaking insights into the implementation of metrics for biomedical image segmentation. arXiv 2410.0263010.48550/arXiv.2410.02630 (2024). [Google Scholar]
- 48.Podobnik, G., Vrtovec, T. & HDilemma Are open-source Hausdorff distance implementations equivalent? In: 27th International Conference on Medical Image Computing and Computer Assisted Intervention – MICCAI 2024, Springer, Lecture Notes in Computer Science, vol. 15009, pp. 308–317, (2024). 10.1007/978-3-031-72114-4_30
- 49.Hurkmans, C. et al. A joint ESTRO and AAPM guideline for development, clinical validation and reporting of artificial intelligence models in radiation therapy. Radiother Oncol.197, 110345. 10.1016/j.radonc.2024.110345 (2024). [DOI] [PubMed] [Google Scholar]
- 50.Maffei, N. et al. Radiomics classifier to quantify automatic segmentation quality of cardiac sub-structures for radiotherapy treatment planning. Phys. Med.83, 278–286. 10.1016/j.ejmp.2021.05.009 (2021). [DOI] [PubMed] [Google Scholar]
- 51.Koo, J., Caudell, J., Latifi, K., Moros, E. & Feygelman, V. Essentially unedited deep-learning-based oars are suitable for rigorous oropharyngeal and laryngeal cancer treatment planning. J. Appl. Clin. Med. Phys.25, e14202. 10.1002/acm2.14202 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Van Aalst, J. et al. Clarifying the dosimetric impact of autosegmentation inaccuracies. In: 20th International Conference on the use of Computers in Radiation therapy – ICCR 2024, pp. 53–56, (2024). https://udl.hal.science/hal-04720234v1
- 53.Liang, B. et al. Extracting 3D Spatial features from dose distribution to predict incidence of radiation pneumonitis. Front. Oncol.9, 269. 10.3389/fonc.2019.00269 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Bisello, S. et al. Dose–volume constraints for organs at risk in radiotherapy (CORSAIR): an all-in-one multicenter–multidisciplinary practical summary. Curr. Oncol.29, 7021–7050. 10.3390/curroncol29100552 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Osorio, E. et al. Dysphagia at 1 year is associated with mean dose to the inferior section of the brain stem. Int. J. Radiat. Oncol. Biol. Phys.117, 903–913. 10.1016/j.ijrobp.2023.06.004 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Baroudi, H. et al. Automated contouring and planning in radiation therapy: what is ‘clinically acceptable’? Diagnostics13, 667. 10.3390/diagnostics13040667 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Sprent, P. & Smeeton, N. C. Applied Nonparametric Statistical Methods, 4th Edition, Chapman and Hall/CRC, (2007).
- 58.Podobnik, G., Strojan, P., Peterlin, P., Ibragimov, B. & Vrtovec, T. Multimodal CT and MR segmentation of head and neck organs-at-risk. In: 26th International Conference on Medical Image Computing and Computer Assisted Intervention – MICCAI 2023, Springer, Lecture Notes in Computer Science, vol. 14223, pp. 745–755, (2023). 10.1007/978-3-031-43901-8_71
- 59.Regulation, E. U. 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices. https://eur-lex.europa.eu/eli/reg/2017/745/ (2017).
- 60.Maier-Hein, L. et al. Metrics reloaded: recommendations for image analysis validation. Nat. Methods. 21, 195–212. 10.1038/s41592-023-02151-z (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Van Dijk, L. et al. Improving automatic delineation for head and neck organs at risk by deep learning contouring. Radiother Oncol.142, 115–123. 10.1016/j.radonc.2019.09.022 (2020). [DOI] [PubMed] [Google Scholar]
- 62.Chen, X. et al. A deep learning-based auto-segmentation system for organs-at-risk on whole-body computed tomography images for radiation therapy. Radiother Oncol.160, 175–184. 10.1016/j.radonc.2021.04.019 (2021). [DOI] [PubMed] [Google Scholar]
- 63.Brunenberg, E. et al. External validation of deep learning-based contouring of head and neck organs at risk. Phys. Imaging Radiat. Oncol.15, 8–15. 10.1016/j.phro.2020.06.006 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Mlynarski, P., Delingette, H., Alghamdi, H., Bondiau, P-Y. & Ayache, N. Anatomically consistent CNN-based segmentation of organs-at-risk in cranial radiotherapy. J. Med. Imaging. 7, 014502–014502. 10.1117/1.JMI.7.1.014502 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Kuperman, V. Y. & Altundal, Y. New index for quantitative comparison of dose distributions in radiotherapy. Med. Phys.52, 4804–4814. 10.1002/mp.17702 (2025). [DOI] [PubMed] [Google Scholar]
- 66.van Rooij, W. et al. Deep learning-based delineation of head and neck organs at risk: geometric and dosimetric evaluation. Int. J. Radiat. Oncol. Biol. Phys.104, 677–684. 10.1016/j.ijrobp.2019.02.040 (2019). [DOI] [PubMed] [Google Scholar]
- 67.Poel, R. et al. The predictive value of segmentation metrics on dosimetry in organs at risk of the brain. Med. Image Anal.73, 102161. 10.1016/j.media.2021.102161 (2021). [DOI] [PubMed] [Google Scholar]
- 68.Guo, H. et al. The dosimetric impact of deep learning-based auto-segmentation of organs at risk on nasopharyngeal and rectal cancer. Radiat. Oncol.16, 113. 10.1186/s13014-021-01837-y (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Marquez, B. et al. Analyzing the relationship between dose and geometric agreement metrics for auto-contouring in head and neck normal tissues. Diagnostics14, 1632. 10.3390/diagnostics14151632 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The HaN-Seg dataset43 is publicly available online (https://doi.org/10.5281/zenodo.7442913). The cases used in this study are available from the corresponding author upon reasonable request.




